Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Investment Tools And Research To Help Make You A More Confident And Profitable Trader. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or

Olema Pharmaceuticals Inc (OLMA)

Olema Pharmaceuticals Inc (OLMA)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 665,431
  • Shares Outstanding, K 57,266
  • Annual Sales, $ 0 K
  • Annual Income, $ -96,660 K
  • EBIT $ -122 M
  • EBITDA $ -121 M
  • 60-Month Beta 2.02
  • Price/Sales N/A
  • Price/Cash Flow N/A
  • Price/Book 2.84

Options Overview Details

View History
  • Implied Volatility 126.20% ( +22.20%)
  • Historical Volatility 39.13%
  • IV Percentile 87%
  • IV Rank 64.21%
  • IV High 177.96% on 10/17/24
  • IV Low 33.34% on 09/12/24
  • Put/Call Vol Ratio 0.00
  • Today's Volume 10
  • Volume Avg (30-Day) 67
  • Put/Call OI Ratio 0.06
  • Today's Open Interest 2,859
  • Open Int (30-Day) 2,884

Analyst Rating / Earnings Estimates

Current Rating
See More
Strong Buy
Based on 9 analysts offering recommendations.
Earnings Estimates - Current Qtr 09/30/24
See More
  • Average Estimate -0.58
  • Number of Estimates 7
  • High Estimate -0.50
  • Low Estimate -0.63
  • Prior Year -0.48
  • Growth Rate Est. (year over year) -20.83%

Price Performance

See More
Period Period Low Period High Performance
1-Month
10.98 +5.83%
on 10/10/24
12.82 -9.36%
on 10/23/24
-0.68 (-5.53%)
since 10/01/24
3-Month
10.91 +6.51%
on 09/04/24
14.41 -19.34%
on 08/07/24
-4.84 (-29.40%)
since 08/01/24
52-Week
8.51 +36.55%
on 05/24/24
17.79 -34.69%
on 11/08/23
-3.32 (-22.22%)
since 11/01/23

Most Recent Stories

More News
Olema Oncology Presents Compelling New Preclinical Data Demonstrating Anti-Tumor Activity for OP-3136 with Enhanced Activity of Palazestrant Combinations at ENA 2024

OLMA : 11.62 (+0.78%)
Olema Oncology Announces New Preclinical Combination Data to be Presented at the 2024 EORTC-NCI-AACR Symposium on Molecular Targets and Cancer Therapeutics

OLMA : 11.62 (+0.78%)
Top Five Cancer Types Dominate New US Cases as Biotech Sector Eyes $314B Market by 2032

/CNW/ -- According to a "highly troubling" new study, the rising number of cancer cases in young people is being attributed to "accelerated aging." Further...

ONCY : 1.1800 (+2.61%)
CELC : 14.93 (-3.68%)
OLMA : 11.62 (+0.78%)
BIO : 368.42 (+2.86%)
AZN : 71.42 (+0.38%)
ONC.TO : 1.66 (+4.40%)
Biotech's Developments in Race Against Rising Cancer Rates Revealed

USA News Group – According to a “highly troubling” new study, the rising number of cancer cases in young people is being attributed to “accelerated aging.” Further alarm is being spread by the...

ONCY : 1.1800 (+2.61%)
ONC.TO : 1.66 (+4.40%)
CELC : 14.93 (-3.68%)
OLMA : 11.62 (+0.78%)
BIO : 368.42 (+2.86%)
AZN : 71.42 (+0.38%)
Stocks Fall as Bond Yields Climb on Strong US Economic News

The S&P 500 Index ($SPX ) (SPY ) this morning is down -1.06%, the Dow Jones Industrials Index ($DOWI ) (DIA ) is down -1.08%, and the Nasdaq 100 Index ($IUXX ) (QQQ ) is down -1.51%. Stock indexes this...

$SPX : 5,728.80 (+0.41%)
SPY : 571.04 (+0.42%)
$DOWI : 42,052.19 (+0.69%)
DIA : 420.42 (+0.66%)
$IUXX : 20,033.14 (+0.72%)
QQQ : 487.43 (+0.74%)
^BTCUSD : 67,868.68 (-1.95%)
ZNZ24 : 110-010s (-0.40%)
HUM : 260.71 (+1.12%)
CVS : 55.81 (-1.15%)
UNH : 567.56 (+0.54%)
CNC : 63.52 (+2.02%)
Stocks Retreat as Bond Yields Jump on Diminished Fed Rate Cut Prospects

The S&P 500 Index ($SPX ) (SPY ) this morning is down -1.02%, the Dow Jones Industrials Index ($DOWI ) (DIA ) is down -1.09%, and the Nasdaq 100 Index ($IUXX ) (QQQ ) is down -1.47%. Stock indexes this...

$SPX : 5,728.80 (+0.41%)
SPY : 571.04 (+0.42%)
$DOWI : 42,052.19 (+0.69%)
DIA : 420.42 (+0.66%)
$IUXX : 20,033.14 (+0.72%)
QQQ : 487.43 (+0.74%)
ZNZ24 : 110-010s (-0.40%)
HUM : 260.71 (+1.12%)
CVS : 55.81 (-1.15%)
UNH : 567.56 (+0.54%)
ELV : 414.01 (+2.03%)
CNC : 63.52 (+2.02%)
How Recent Biotech Breakthroughs Are Changing the Fight Against Breast Cancer

USA News Group – More people are getting breast cancer this year. Around 300,000 women and 2,800 men will find out they have it. While 1 out of every 8 women will hear they have breast cancer sometime...

ONCY : 1.1800 (+2.61%)
ONC.TO : 1.66 (+4.40%)
PFE : 28.09 (-0.74%)
ARVN : 26.90 (+1.78%)
OLMA : 11.62 (+0.78%)
AZN : 71.42 (+0.38%)
How Recent Biotech Breakthroughs Are Changing the Fight Against Breast Cancer

USA News Group – More people are getting breast cancer this year. Around 300,000 women and 2,800 men will find out they have it. While 1 out of every 8 women will hear they have breast cancer sometime...

AVRN : 0.0125 (-30.56%)
ONCY : 1.1800 (+2.61%)
ONC.TO : 1.66 (+4.40%)
PFE : 28.09 (-0.74%)
ARVN : 26.90 (+1.78%)
OLMA : 11.62 (+0.78%)
AZN : 71.42 (+0.38%)
Olema Oncology Reports Second Quarter 2022 Financial Results and Provides Corporate Update

Received Fast Track designation from U.S. FDA for OP-1250 for the treatment of ER+/HER2- metastatic breast cancerReported progress across OP-1250 clinical...

OLMA : 11.62 (+0.78%)
Olema Oncology Advances OP-1250 into Phase 2 Monotherapy Expansion in Patients with ER+/HER2- Advanced Breast Cancer

SAN FRANCISCO, Aug. 09, 2022 (GLOBE NEWSWIRE) -- Olema Pharmaceuticals, Inc. (“Olema” or “Olema Oncology,” Nasdaq: OLMA), today announced the advancement...

OLMA : 11.62 (+0.78%)

Business Summary

Olema Pharmaceuticals Inc. is a clinical-stage biopharmaceutical company. It engages in discovery, development and commercialization of therapies for women's cancers. The company's product pipeline includes OP-1250, which is in clinical stage. Olema Pharmaceuticals Inc. is based in San Francisco, California....

See More

Key Turning Points

3rd Resistance Point 12.30
2nd Resistance Point 12.12
1st Resistance Point 11.87
Last Price 11.62
1st Support Level 11.44
2nd Support Level 11.26
3rd Support Level 11.01

See More

52-Week High 17.79
Fibonacci 61.8% 14.25
Fibonacci 50% 13.15
Fibonacci 38.2% 12.06
Last Price 11.62
52-Week Low 8.51

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.

Free Barchart Webinar